{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:39:17Z","timestamp":1787751557431,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T00:00:00Z","timestamp":1281398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11916-010-0138-2","type":"journal-article","created":{"date-parts":[[2010,8,9]],"date-time":"2010-08-09T04:06:15Z","timestamp":1281326775000},"page":"376-384","source":"Crossref","is-referenced-by-count":14,"title":["Management of Menstrual Migraine: A Review of Current Abortive and Prophylactic Therapies"],"prefix":"10.1007","volume":"14","author":[{"given":"Elizabeth","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Bushnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,10]]},"reference":[{"key":"138_CR1","first-page":"159","volume-title":"Epidemiology of Pain","author":"AI Scher","year":"1999","unstructured":"Scher AI, Stewart WF, Lipton RB: Migraine and headache: a meta-analytic approach. In Epidemiology of Pain. Edited by Crombie IK, Croft PR, Linton SJ, et al. Seattle: IASP Press; 1999:159\u2013170."},{"key":"138_CR2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/oxfordjournals.aje.a116014","volume":"134","author":"WF Stewart","year":"1991","unstructured":"Stewart WF, Linet MS, Celentano DD, et al.: Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991, 134:1111\u20131120.","journal-title":"Am J Epidemiol"},{"issue":"6 Suppl 4","key":"138_CR3","first-page":"S24","volume":"44","author":"WF Stewart","year":"1994","unstructured":"Stewart WF, Schechter A, Lipton RB: Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology 1994, 44(6 Suppl 4):S24\u2013S39.","journal-title":"Neurology"},{"key":"138_CR4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.55.10.1517","volume":"55","author":"WF Stewart","year":"2000","unstructured":"Stewart WF, Lipton RB, Chee E, et al.: Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000, 55:1517\u20131523.","journal-title":"Neurology"},{"key":"138_CR5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1526-4610.2005.05064.x","volume":"45","author":"AJ Dowson","year":"2005","unstructured":"Dowson AJ, Kilminster SG, Salt R, et al.: Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study. Headache 2005, 45:274\u2013282.","journal-title":"Headache"},{"key":"138_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/01.WNL.0000133134.68143.2E","volume":"63","author":"EA MacGregor","year":"2004","unstructured":"MacGregor EA, Hackshaw A: Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004, 63:351\u2013353.","journal-title":"Neurology"},{"key":"138_CR7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1468-2982.2004.00741.x","volume":"24","author":"F Granella","year":"2004","unstructured":"Granella F, Sances G, Allais G, et al.: Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004, 24:707\u2013716.","journal-title":"Cephalalgia"},{"key":"138_CR8","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1526-4610.2005.00242.x","volume":"45","author":"VT Martin","year":"2005","unstructured":"Martin VT, Wernke S, Mandell K, et al.: Defining the relationship between ovarian hormones and migraine headache. Headache 2005, 45:1190\u20131201.","journal-title":"Headache"},{"key":"138_CR9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1212\/WNL.22.4.355","volume":"22","author":"BW Somerville","year":"1972","unstructured":"Somerville BW: The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972, 22:355\u2013365.","journal-title":"Neurology"},{"key":"138_CR10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1212\/WNL.21.8.853","volume":"21","author":"BW Somerville","year":"1971","unstructured":"Somerville BW: The role of progesterone in menstrual migraine. Neurology 1971, 21:853\u2013859.","journal-title":"Neurology"},{"issue":"Suppl 3","key":"138_CR11","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1111\/j.1526-4610.2008.01310.x","volume":"48","author":"VT Martin","year":"2008","unstructured":"Martin VT, Lipton RB: Epidemiology and biology of menstrual migraine. Headache 2008, 48(Suppl 3):S124\u2013S130.","journal-title":"Headache"},{"key":"138_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1526-4610.1997.3704235.x","volume":"37","author":"C Lokken","year":"1997","unstructured":"Lokken C, Holm JE, Myers TC: The menstrual cycle and migraine: a time-series analysis of 20 women migraineurs. Headache 1997, 37:235\u2013239.","journal-title":"Headache"},{"key":"138_CR13","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jama.295.15.1824","volume":"295","author":"JL Brandes","year":"2006","unstructured":"Brandes JL: The influence of estrogen on migraine: a systematic review. JAMA 2006, 295:1824\u20131830.","journal-title":"JAMA"},{"key":"138_CR14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11916-008-0077-3","volume":"12","author":"VT Martin","year":"2008","unstructured":"Martin VT: New theories in the pathogenesis of menstrual migraine. Curr Pain Headache Rep 2008, 12:453\u2013462.","journal-title":"Curr Pain Headache Rep"},{"issue":"Suppl 1","key":"138_CR15","first-page":"9","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9\u2013160.","journal-title":"Cephalalgia"},{"key":"138_CR16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1526-4610.2008.01310.x","volume":"48","author":"V Martin","year":"2008","unstructured":"\u2022 Martin V, Cady R, Mauskop A, et al.: Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. Headache 2008, 48:226\u2013235. This well-modeled study evaluated the efficacy of rizatriptan in a subgroup of menstrual migraineurs from the larger TAME study.","journal-title":"Headache"},{"key":"138_CR17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1468-2982.2007.01313.x","volume":"27","author":"LK Mannix","year":"2007","unstructured":"Mannix LK, Loder E, Nett R, et al.: Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. Cephalalgia 2007, 27:414\u2013421.","journal-title":"Cephalalgia"},{"key":"138_CR18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1526-4610.2008.01093.x","volume":"48","author":"R Nett","year":"2008","unstructured":"Nett R, Mannix LK, Mueller L, et al.: Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. Headache 2008, 48:1194\u20131201.","journal-title":"Headache"},{"key":"138_CR19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/jwh.2008.1031","volume":"18","author":"LC Newman","year":"2009","unstructured":"Newman LC, Harper S, Jones BA, Campbell J: Frovatriptan for acute treatment of migraine associated with menstruation: Results from an open-label postmarketing surveillance study. J Women\u2019s Health (Larchmt) 2009, 18:1265\u20131273.","journal-title":"J Women\u2019s Health (Larchmt)"},{"key":"138_CR20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1368-5031.2004.00295.x","volume":"58","author":"S Landy","year":"2004","unstructured":"Landy S, Savani N, Shackelford S, et al.: Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Int J Clin Pract 2004, 58:913\u2013919.","journal-title":"Int J Clin Pract"},{"key":"138_CR21","first-page":"835","volume":"102","author":"R Nett","year":"2003","unstructured":"Nett R, Landy S, Shackelford S, et al.: Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 2003, 102:835\u2013842.","journal-title":"Obstet Gynecol"},{"key":"138_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","volume":"114","author":"LK Mannix","year":"2009","unstructured":"\u2022 Mannix LK, Martin VT, Cady RK, et al.: Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials. Obstet Gynecol 2009, 114:106\u2013113. This randomized, double-blind, multicenter, placebo-controlled trial examines the efficacy of sumatriptan\u2013naproxen in menstrual migraine and connects this with efficacy in dysmenorrhea.","journal-title":"Obstet Gynecol"},{"key":"138_CR23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2165\/00023210-200620120-00005","volume":"20","author":"M Tuchman","year":"2006","unstructured":"Tuchman M, Hee A, Emeribe U, Silberstein S: Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS Drugs 2006, 20:1019\u20131026.","journal-title":"CNS Drugs"},{"issue":"Suppl 2","key":"138_CR24","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1007\/s10072-007-0783-3","volume":"28","author":"G Allais","year":"2007","unstructured":"Allais G, Bussone G, De Lorenzo C, et al.: Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations. Neurol Sci 2007, 28(Suppl 2):S225\u2013S228.","journal-title":"Neurol Sci"},{"issue":"Suppl 13","key":"138_CR25","first-page":"244","volume":"13","author":"V Pfaffenrath","year":"1993","unstructured":"Pfaffenrath V: Efficacy and safety of percutaneous estradiol vs placebo in menstrual migraine. Cephalalgia 1993, 13(Suppl 13):244.","journal-title":"Cephalalgia"},{"key":"138_CR26","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.fertnstert.2004.12.048","volume":"83","author":"KD LaGuardia","year":"2005","unstructured":"LaGuardia KD, Fisher AC, Bainbridge JD, et al.: Suppression of estrogen-withdrawal headache with extended transdermal contraception. Fertil Steril 2005, 83:1875\u20131877.","journal-title":"Fertil Steril"},{"key":"138_CR27","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"\u2022 MacGregor EA, Frith A, Ellis J, et al.: Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006, 67:2159\u20132163. This double-blind, placebo-controlled, crossover study evaluates the efficacy of estradiol gel in reduction of menstrual migraine.","journal-title":"Neurology"},{"key":"138_CR28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.51.1.307","volume":"51","author":"LC Newman","year":"1998","unstructured":"Newman LC, Lipton RB, Lay CL, Solomon S: A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998, 51:307\u2013309.","journal-title":"Neurology"},{"key":"138_CR29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00023210-200822100-00007","volume":"22","author":"MM Tuchman","year":"2008","unstructured":"\u2022 Tuchman MM, Hee A, Emeribe U, Silberstein S: Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study. CNS Drugs 2008, 22:877\u2013886. This well-designed study evaluated the efficacy of two dosing regimens of zolmitriptan for intermittent prophylaxis of menstrual migraine.","journal-title":"CNS Drugs"},{"key":"138_CR30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1526-4610.2001.111006248.x","volume":"41","author":"L Newman","year":"2001","unstructured":"Newman L, Mannix LK, Landy S, et al.: Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001, 41:248\u2013256.","journal-title":"Headache"},{"issue":"Suppl 2","key":"138_CR31","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1007\/s10072-005-0435-4","volume":"26","author":"F Moschiano","year":"2005","unstructured":"Moschiano F, Allais G, Grazzi L, et al.: Naratriptan in the short-term prophylaxis of pure menstrual migraine. Neurol Sci 2005, 26(Suppl 2):S162\u2013S166.","journal-title":"Neurol Sci"},{"key":"138_CR32","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1526-4610.2007.00855.x","volume":"47","author":"LK Mannix","year":"2007","unstructured":"Mannix LK, Savani N, Landy S, et al.: Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 2007, 47:1037\u20131049.","journal-title":"Headache"},{"key":"138_CR33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/01.WNL.0000134620.30129.D6","volume":"63","author":"SD Silberstein","year":"2004","unstructured":"Silberstein SD, Elkind AH, Schreiber C, Keywood C: A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004, 63:261\u2013269.","journal-title":"Neurology"},{"key":"138_CR34","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1526-4610.2009.01509.x","volume":"49","author":"SD Silberstein","year":"2009","unstructured":"Silberstein SD, Berner T, Tobin J, et al.: Scheduled short-term prevention with frovatriptan for mi-graine occurring exclusively in association with menstruation. Headache 2009, 49:1283\u20131297.","journal-title":"Headache"},{"key":"138_CR35","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1468-2982.2009.01840.x","volume":"29","author":"JL Brandes","year":"2009","unstructured":"Brandes JL, Poole A, Kallela M, et al.: Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia 2009, 29:1133\u20131148.","journal-title":"Cephalalgia"},{"key":"138_CR36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10194-007-0417-4","volume":"8","author":"M Guidotti","year":"2007","unstructured":"Guidotti M, Mauri M, Barril\u00e0 C, et al.: Frovatriptan vs. transdermal estrogens or naproxen sodium for the prophylaxis of menstrual migraine. J Headache Pain 2007, 8:283\u2013288.","journal-title":"J Headache Pain"},{"key":"138_CR37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00044011-200929050-00005","volume":"29","author":"A Wade","year":"2009","unstructured":"\u2022 Wade A, Pawsey S, Whale H, et al.: Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers. Clin Drug Investig 2009, 29:325\u2013337. This very useful study evaluates the pharmacodynamics of frovatriptan and evaluates serum levels with different dosing regimens.","journal-title":"Clin Drug Investig"},{"key":"138_CR38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1526-4610.2006.00710.x","volume":"47","author":"E Loder","year":"2007","unstructured":"\u2022 Loder E, Rizzoli P, Golub J: Hormonal management of migraine associated with menses and the menopause: A clinical review. Headache 2007, 47:329\u2013340. This is an excellent review of current data regarding estrogen and migraine treatment.","journal-title":"Headache"},{"key":"138_CR39","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2165\/00003495-200464220-00002","volume":"64","author":"TR Smith","year":"2004","unstructured":"Smith TR, Stoneman J: Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management. Drugs 2004, 64:2503\u20132514.","journal-title":"Drugs"},{"key":"138_CR40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1524-4733.2005.00056.x","volume":"8","author":"EM Perfetto","year":"2005","unstructured":"Perfetto EM, Weis KA, Mullins CD, et al.: An economic evaluation of triptan products for migraine. Value Health 2005, 8:647\u2013655.","journal-title":"Value Health"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-010-0138-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-010-0138-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-010-0138-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:38:27Z","timestamp":1559435907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-010-0138-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1007\/s11916-010-0138-2","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,10]]}}}